Heteron Biotechnologies, LLC, is developing novel in-vitro breath diagnostic devices and methods of testing to be marketed as over-the-counter (OTC) devices for self-testing and as point-of-care (POC) devices for in-vitro diagnosis in a non-facility-centric model, which will improve disease outcomes and will lower health care cost, significantly.
These low-cost, autonomous, stand-alone, AI-enhanced, hand-held breath analyzer devices detect gases in breath and are used as screening, diagnostic and monitoring tools for large segments of populations with high prevalence of gastrointestinal, liver and metabolic diseases.
Heteron Biotechnologies, LLC, is developing novel in-vitro breath diagnostic devices and methods of testing to be marketed as over-the-counter (OTC) devices for self-testing and as point-of-care (POC) devices for in-vitro diagnosis in a non-facility-centric model, which will improve disease outcomes and will lower health care cost, significantly.
These low-cost, autonomous, stand-alone, AI-enhanced, hand-held breath analyzer devices detect gases in breath and are used as screening, diagnostic and monitoring tools for large segments of populations with high prevalence of gastrointestinal, liver and metabolic diseases.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy